ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,304.72
0.70%
Dow Jones
39,069.59
0.01%
US Dollar vs MXN
16.6998
0.00%
Brent Oil
81.965
0.00%
Bitcoin
68,755.63
0.33%
Registration Strip Icon for charts Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Theratechnologies Inc (THTX)

  7. Theratechnologies Inc (THTX) Noticias

THTX

Theratechnologies (THTX)

Theratechnologies Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:THTX
FechaHoraFuenteTítuloSímboloCompañía
23/05/202416:00GlobeNewswire Inc.Theratechnologies’ Sudocetaxel Zendusortide ASCO 2024 Presentation Demonstrates Signs of Long-Term Efficacy and Manageable Safety Profile in Patients with Solid TumorsNASDAQ:THTXTheratechnologies Inc
10/05/202412:10Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:THTXTheratechnologies Inc
09/05/202415:30GlobeNewswire Inc.Theratechnologies Reports on its Annual Meeting of ShareholdersNASDAQ:THTXTheratechnologies Inc
02/05/202406:30GlobeNewswire Inc.Theratechnologies to Present Long-Term Efficacy, Safety and Pharmacokinetic Data on Use of TH1902 (sudocetaxel zendusortide) in Solid Tumors at 2024 ASCO MeetingNASDAQ:THTXTheratechnologies Inc
15/04/202415:15GlobeNewswire Inc.Theratechnologies Announces Mailing of Management Proxy Circular in Connection with its Annual Meeting of ShareholdersNASDAQ:THTXTheratechnologies Inc
11/04/202406:30GlobeNewswire Inc.Theratechnologies to Present at the 2024 Bloom Burton & Co. Healthcare Investor ConferenceNASDAQ:THTXTheratechnologies Inc
10/04/202406:30GlobeNewswire Inc.Theratechnologies Reports Financial Results and Provides Business Update for First Quarter 2024NASDAQ:THTXTheratechnologies Inc
10/04/202406:15IH Market NewsU.S. Index Futures Show Mixed Trend Ahead of Key Inflation Data Release, Oil Prices Edge HigherNASDAQ:THTXTheratechnologies Inc
08/04/202415:30GlobeNewswire Inc.Theratechnologies Preclinical Data Presentation at AACR 2024 Highlights Versatility and Flexibility of SORT1+ Technology™ Oncology PlatformNASDAQ:THTXTheratechnologies Inc
05/04/202410:00GlobeNewswire Inc.Theratechnologies Appoints Elina Tea to its Board of DirectorsNASDAQ:THTXTheratechnologies Inc
03/04/202406:30GlobeNewswire Inc.Theratechnologies to Announce First Quarter 2024 Financial Results and Provide Business UpdateNASDAQ:THTXTheratechnologies Inc
28/03/202406:30GlobeNewswire Inc.Theratechnologies to Present Preclinical Data at AACR on Multiple PDCs Showcasing Potential of SORT1+Technology™ PlatformNASDAQ:THTXTheratechnologies Inc
22/03/202408:36GlobeNewswire Inc.Theratechnologies Announces Update on its Preclinical Oncology Research ProgramNASDAQ:THTXTheratechnologies Inc
21/03/202419:00GlobeNewswire Inc.Theratechnologies Appoints Jordan Zwick to its Board of DirectorsNASDAQ:THTXTheratechnologies Inc
21/03/202406:30GlobeNewswire Inc.Theratechnologies Initiates Increased Dose Level in Phase 1 Clinical Trial of Sudocetaxel Zendusortide in Advanced Ovarian CancerNASDAQ:THTXTheratechnologies Inc
29/02/202415:34GlobeNewswire Inc.Theratechnologies Announces the Resignation of One of Its Directors, Mr. Alain TrudeauNASDAQ:THTXTheratechnologies Inc
27/02/202406:30GlobeNewswire Inc.Theratechnologies Receives Refusal to File Letter for Trogarzo® Intramuscular Method of Administration sBLA from FDANASDAQ:THTXTheratechnologies Inc
21/02/202407:01Edgar (US Regulatory)Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]NASDAQ:THTXTheratechnologies Inc
21/02/202406:30GlobeNewswire Inc.Theratechnologies Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2023 and Provides 2024 GuidanceNASDAQ:THTXTheratechnologies Inc
20/02/202406:30GlobeNewswire Inc.Theratechnologies Announces Publication in Frontiers in Immunology that Deepens Understanding of Sudocetaxel Zendusortide (TH1902) Molecular Mechanism of ActionNASDAQ:THTXTheratechnologies Inc
15/02/202406:30GlobeNewswire Inc.Theratechnologies Completes Enrollment of First Six Patients in Updated Phase 1 Clinical Trial of Sudocetaxel Zendusortide in Advanced Ovarian CancerNASDAQ:THTXTheratechnologies Inc
06/02/202406:30GlobeNewswire Inc.Theratechnologies to Announce Fourth Quarter and Full Year 2023 Financial Results and Provide Business UpdateNASDAQ:THTXTheratechnologies Inc
24/01/202406:00GlobeNewswire Inc.Theratechnologies Receives Complete Response Letter (CRL) from the FDA for the F8 Formulation of Tesamorelin sBLANASDAQ:THTXTheratechnologies Inc
23/01/202406:30GlobeNewswire Inc.Theratechnologies Receives Update from FDA on Tesamorelin F8 Supplemental Biologic License ApplicationNASDAQ:THTXTheratechnologies Inc
03/01/202423:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:THTXTheratechnologies Inc
02/01/202415:28Edgar (US Regulatory)Form F-3/A - Registration statement by foreign private issuers: [Amend]NASDAQ:THTXTheratechnologies Inc
02/01/202408:00AllPennyStocks.comWill This Dual-Listed Bio-Pharma Catch New Year Action?NASDAQ:THTXTheratechnologies Inc
02/01/202406:30GlobeNewswire Inc.Theratechnologies Submits sBLA for Trogarzo® Intramuscular (IM) Method of Administration to FDANASDAQ:THTXTheratechnologies Inc
21/12/202315:12PR Newswire (Canada)Theratechnologies annonce le renouvellement de son prospectus préalable et le dépôt de sa déclaration d'inscriptionNASDAQ:THTXTheratechnologies Inc
21/12/202315:09PR Newswire (Canada)Theratechnologies Announces Renewal of Shelf Prospectus and Filing of Registration StatementNASDAQ:THTXTheratechnologies Inc
 Showing the most relevant articles for your search:NASDAQ:THTX

Su Consulta Reciente

USOTC
RHHBY
Roche (QX)
COIN
BTCUSD
Bitcoin
PM
XAUUSD
Gold vs US Dollar
NYSE
MCD
McDonalds
COIN
SOLUSD
Solana
USOTC
BASFY
BASF (QX)
NASDAQ
NVDA
NVIDIA
NYSE
KO
Coca Cola
USOTC
ADDYY
Adidas (QX)
FX
EURUSD
Euro vs US Dollar
NASDAQ
MSFT
Microsoft
USI
USTECH100
US Tech 100
CCOM
OILBRENT
Brent Oil
CCOM
US30
US 30
NYSE
CVX
Chevron
NYSE
VZ
Verizon Communications
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados